Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-10-08 Sale | 2025-10-10 4:01 pm | OCULAR THERAPEUTIX INC | OCUL | Anderman Todd Chief Legal Officer | 11,132 | $12.34 | $137,369 | 87,568 (Direct) | View |
| 2025-10-02 Sale | 2025-10-06 5:13 pm | OCULAR THERAPEUTIX INC | OCUL | Kaiser Peter Chief Development Officer | 9,653 | $11.03 | $106,473 | 194,440 (Direct) | View |
| 2025-10-02 Sale | 2025-10-06 5:10 pm | OCULAR THERAPEUTIX INC | OCUL | Heier Jeffrey S. Chief Scientific Officer | 10,502 | $11.04 | $115,942 | 249,409 (Direct) | View |
| 2025-09-02 Sale | 2025-09-04 4:50 pm | OCULAR THERAPEUTIX INC | OCUL | Notman Donald See Remarks | 1,066 | $12.43 | $13,250 | 308,807 (Direct) | View |
| 2025-08-25 Sale | 2025-08-27 6:44 pm | OCULAR THERAPEUTIX INC | OCUL | Kaiser Peter Chief Development Officer | 3,011 | $12.04 | $36,252 | 204,093 (Direct) | View |
| 2025-08-25 Sale | 2025-08-27 6:43 pm | OCULAR THERAPEUTIX INC | OCUL | Nayak Sanjay Chief Strategy Officer | 1,885 | $12.04 | $22,695 | 279,738 (Direct) | View |
| 2025-08-25 Sale | 2025-08-27 6:42 pm | OCULAR THERAPEUTIX INC | OCUL | Heier Jeffrey S. Chief Scientific Officer | 3,063 | $12.04 | $36,879 | 259,911 (Direct) | View |
| 2025-08-25 Sale | 2025-08-27 6:41 pm | OCULAR THERAPEUTIX INC | OCUL | Dugel Pravin See Remarks | 21,494 | $12.04 | $258,788 | 3,477,605 (Indirect Direct) | View |
| 2025-06-02 Sale | 2025-06-03 4:20 pm | OCULAR THERAPEUTIX INC | OCUL | Waheed Nadia Chief Medical Officer | 13,861 | $8.05 | $111,581 | 206,805 (Direct) | View |
| 2025-05-23 Sale | 2025-05-27 5:42 pm | OCULAR THERAPEUTIX INC | OCUL | Nayak Sanjay Chief Strategy Officer | 1,862 | $7.17 | $13,351 | 281,623 (Direct) | View |
| 2025-05-23 Sale | 2025-05-27 5:40 pm | OCULAR THERAPEUTIX INC | OCUL | Kaiser Peter Chief Development Officer | 2,974 | $7.17 | $21,324 | 207,104 (Direct) | View |
| 2025-05-23 Sale | 2025-05-27 5:39 pm | OCULAR THERAPEUTIX INC | OCUL | Heier Jeffrey S. Chief Scientific Officer | 3,024 | $7.18 | $21,712 | 262,974 (Direct) | View |
| 2025-05-23 Sale | 2025-05-27 5:37 pm | OCULAR THERAPEUTIX INC | OCUL | Dugel Pravin See Remarks | 21,219 | $7.18 | $152,352 | 3,499,099 (Direct) | View |
| 2025-05-08 Purchase | 2025-05-12 8:50 pm | OCULAR THERAPEUTIX INC | OCUL | LINDSTROM RICHARD L MD Director | 10,000 | $6.96 | $69,600 | 172,704 (Direct) | View |
| 2025-02-24 Sale | 2025-02-26 6:27 pm | OCULAR THERAPEUTIX INC | OCUL | Dugel Pravin See Remarks | 21,475 | $6.87 | $147,533 | 3,520,318 (Direct) | View |
| 2025-02-24 Sale | 2025-02-26 6:25 pm | OCULAR THERAPEUTIX INC | OCUL | Heier Jeffrey S. Chief Scientific Officer | 3,061 | $6.87 | $21,029 | 265,998 (Direct) | View |
| 2025-02-24 Sale | 2025-02-26 6:24 pm | OCULAR THERAPEUTIX INC | OCUL | Kaiser Peter Chief Development Officer | 3,009 | $6.87 | $20,672 | 210,078 (Direct) | View |
| 2025-02-24 Sale | 2025-02-26 6:22 pm | OCULAR THERAPEUTIX INC | OCUL | Nayak Sanjay Chief Strategy Officer | 1,895 | $6.84 | $12,962 | 283,485 (Direct) | View |
| 2025-01-31 Sale | 2025-02-04 7:16 pm | OCULAR THERAPEUTIX INC | OCUL | Notman Donald See Remarks | 17,420 | $7.8209 | $136,239 | 193,444 (Direct) | View |
| 2024-11-25 Sale | 2024-11-27 07:52 am | OCULAR THERAPEUTIX INC | OCUL | Heier Jeffrey S. Chief Scientific Officer | 2,948 | $9.01 | $26,561 | 269,059 (Direct) | View |
| 2024-11-25 Sale | 2024-11-27 07:51 am | OCULAR THERAPEUTIX INC | OCUL | Kaiser Peter Chief Development Officer | 2,897 | $9.01 | $26,102 | 213,087 (Direct) | View |
| 2024-11-25 Sale | 2024-11-27 07:49 am | OCULAR THERAPEUTIX INC | OCUL | Nayak Sanjay Chief Strategy Officer | 1,814 | $9 | $16,326 | 174,380 (Direct) | View |
| 2024-11-25 Sale | 2024-11-27 07:47 am | OCULAR THERAPEUTIX INC | OCUL | Dugel Pravin See Remarks | 20,680 | $9.01 | $186,327 | 791,793 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-09-09 Gift | 2025-09-11 4:06 pm | N/A N/A | OCULAR THERAPEUTIX INC | OCUL | Dugel Pravin See Remarks | 49,754 | $0 | 3,477,605 (Direct) | View |
| 2025-08-12 Option Award | 2025-08-14 5:51 pm | N/A 2035-08-11 | OCULAR THERAPEUTIX INC | OCUL | Waheed Nadia Chief Medical Officer | 163,286 | $0 | 370,091 (Direct) | View |
| 2025-04-28 Gift | 2025-08-13 7:02 pm | N/A N/A | OCULAR THERAPEUTIX INC | OCUL | Dugel Pravin See Remarks | 500,722 | $0 | 3,499,099 (Direct) | View |
Ownership | 2025-06-23 9:12 pm | N/A N/A | OCULAR THERAPEUTIX INC | OCUL | Meyers Steve Lawrence Chief Commercial Officer | 0 | $0 | 664,728 (Direct) | View |
Ownership | 2025-06-23 9:09 pm | N/A N/A | OCULAR THERAPEUTIX INC | OCUL | Saroj Namrata Chief Business Officer | 0 | $0 | 666,000 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:26 pm | N/A 2035-02-11 | OCULAR THERAPEUTIX INC | OCUL | Dugel Pravin See Remarks | 2,750,000 | $0 | 2,750,000 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:26 pm | N/A 2035-06-10 | OCULAR THERAPEUTIX INC | OCUL | Hong Seung Suh Director | 58,000 | $0 | 90,933 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:25 pm | N/A 2035-06-10 | OCULAR THERAPEUTIX INC | OCUL | RAINES MERILEE Director | 58,000 | $0 | 90,933 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:24 pm | N/A 2035-06-10 | OCULAR THERAPEUTIX INC | OCUL | LINDSTROM RICHARD L MD Director | 58,000 | $0 | 230,704 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:24 pm | N/A 2035-06-10 | OCULAR THERAPEUTIX INC | OCUL | Williams Leslie J. Director | 58,000 | $0 | 95,433 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:23 pm | N/A 2035-06-10 | OCULAR THERAPEUTIX INC | OCUL | Warden Charles M Director | 58,000 | $0 | 130,464 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:21 pm | N/A 2035-06-10 | OCULAR THERAPEUTIX INC | OCUL | Graves Adrienne L Director | 58,000 | $0 | 94,000 (Direct) | View |
| 2025-02-11 Option Award | 2025-02-13 8:38 pm | N/A N/A | OCULAR THERAPEUTIX INC | OCUL | Dugel Pravin See Remarks | 2,750,000 | $0 | 3,541,793 (Direct) | View |
| 2025-02-11 Option Award | 2025-02-13 8:37 pm | N/A 2035-02-10 | OCULAR THERAPEUTIX INC | OCUL | Waheed Nadia Chief Medical Officer | 316,000 | $0 | 457,666 (Direct) | View |
| 2025-02-11 Option Award | 2025-02-13 8:36 pm | N/A 2035-02-10 | OCULAR THERAPEUTIX INC | OCUL | Notman Donald See Remarks | 459,115 | $0 | 652,559 (Direct) | View |
| 2025-02-11 Option Award | 2025-02-13 8:35 pm | N/A 2035-02-10 | OCULAR THERAPEUTIX INC | OCUL | Nayak Sanjay Chief Strategy Officer | 445,000 | $0 | 619,380 (Direct) | View |
| 2024-10-07 Option Award | 2024-10-09 5:32 pm | N/A 2034-10-06 | OCULAR THERAPEUTIX INC | OCUL | Anderman Todd Chief Legal Officer | 395,200 | $0 | 395,200 (Direct) | View |